Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012
Operating activities
Net income	$ 134,644		$ 142,982
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	117,195		106,838
Amortization of intangible and other assets and favorable/unfavorable leases	2,970		3,216
Amortization of long-term prepaid rents	2,104		1,988
Amortization of debt issue costs	4,165		3,575
Amortization of deferred revenues, deferred lease incentives and other	(8,478)		(6,890)
Amortization of accumulated other comprehensive loss related to terminated interest rate swap agreement			2,470
Fair value change in interest rate swap agreements not designated as hedges			(761)
Amortization of bond discount	482		692
Impairment of long-lived assets	2,076		1,472
Share based awards compensation expense	10,346		10,165
(Gain) loss on sale of assets and other	(2,532)		8,004
Write-off of unamortized debt discount and debt issue costs related to early retirement of debt	15,688
Deferred lease expenses	4,038		3,327
Deferred income tax expenses	(34,087)		6,935
Equity in income of affiliates	(15,839)		(9,622)
Interest paid on redemption of senior notes	(8,054)
Distributions from equity investees	7,645		4,563
Changes in assets and liabilities	(53,870)		(4,779)
Net cash provided by operating activities	178,493		274,175
Investing activities
Additions to theatre properties and equipment	(159,488)		(146,527)
Proceeds from sale of theatre properties and equipment	29,880		737
Acquisitions of theatres in U.S., net of cash acquired	(259,247)		(14,080)
Investment in DCIP and other	(5,080)		(1,375)
Net cash used for investing activities	(393,935)		(161,245)
Financing activities
Proceeds from stock option exercises	58		4
Payroll taxes paid as a result of restricted stock withholdings	(3,464)		(3,263)
Dividends paid to stockholders	(77,191)	[1]	(72,236)
Issuance of senior notes	530,000
Other short-term borrowings	1,473
Redemption of senior notes	(461,946)
Repayments of long-term debt	(7,060)		(9,051)
Payment of debt issue costs	(9,328)
Payments on capital leases	(8,480)		(6,958)
Purchase of noncontrolling interest share of Adamark S.A., a Brazilian subsidiary	(5,621)
Other	2,861		39
Net cash used for financing activities	(38,698)		(91,465)
Effect of exchange rate changes on cash and cash equivalents	(8,745)		(2,114)
Increase (decrease) in cash and cash equivalents	(262,885)		19,351
Cash and cash equivalents:
Beginning of period	742,664		521,408
End of period	$ 479,779		$ 540,759

[1] Below is a summary of dividends paid to stockholders during the nine months ended September 30, 2013: Declaration Date Record Date Date Paid Amount per Share of Common Stock Total Amount Paid 02/12/13 03/04/13 03/15/13 $ 0.21 $ 24,140 05/24/13 06/06/13 06/20/13 $ 0.21 24,216 08/15/13 08/28/13 09/12/13 $ 0.25 28,835 Total $ 0.67 $ 77,191